CRISPR Therapeutics AG (CRSP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CRISPR Therapeutics AG

    NASDAQ: CRSP · Real-Time Price · USD
    67.74
    -5.08 (-6.98%)
    At close: Oct 03, 2025, 3:59 PM
    68.00
    0.38%
    After-hours: Oct 03, 2025, 07:57 PM EDT

    CRISPR Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 298.26M 389.48M 211.88M 923.03M
    Short-Term Investments
    		 1.61B 1.3B 1.6B 1.46B
    Long-Term Investments
    		 n/a 1.97M 53.13M 16.91M
    Other Long-Term Assets
    		 27.35M 13.57M 16.27M 22.2M
    Receivables
    		 25M 200M n/a 305K
    Inventory
    		 n/a n/a -11.2M n/a
    Other Current Assets
    		 8.31M 14.39M 37.71M n/a
    Total Current Assets
    		 1.94B 1.91B 1.85B 2.42B
    Property-Plant & Equipment
    		 277.55M 305.94M 320.56M 312.04M
    Goodwill & Intangibles
    		 n/a 16K 71K 125K
    Total Long-Term Assets
    		 304.9M 321.49M 390.03M 334.36M
    Total Assets
    		 2.24B 2.23B 2.24B 2.75B
    Account Payables
    		 14.71M 38.15M 27.43M 14.82M
    Deferred Revenue
    		 3.85M 4.11M 12.32M 1.01M
    Short-Term Debt
    		 17.29M 27.99M 15.84M 12.16M
    Other Current Liabilities
    		 51.94M 33.13M 42.62M 55.35M
    Total Current Liabilities
    		 87.78M 108.79M 121.11M 119.88M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 3.44M 958K 5.97M 7.34M
    Total Long-Term Liabilities
    		 222.17M 237.98M 246.47M 232.53M
    Total Liabilities
    		 309.95M 346.77M 367.58M 352.42M
    Total Debt
    		 223.69M 238.63M 244.02M 225.03M
    Book Value
    		 1.93B 1.88B 1.88B 2.4B
    Book Value Per Share
    		 22.90 23.77 24.12 31.59
    Common Stock
    		 2.7M 2.5M 2.44M 2.39M
    Retained Earnings
    		 -1.37B -999.7M -846.09M -195.91M
    Comprehensive Income
    		 1.84M 1.91M -15.65M -5.07M
    Shareholders Equity
    		 1.93B 1.88B 1.88B 2.4B
    Total Investments
    		 1.61B 1.31B 1.66B 1.46B

    Add to Watchlist